SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-12.31%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$146M
AUM Growth
+$146M
(+18%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
30.12%
Top 10 Holdings %
Top 10 Hldgs %
57.31%
Holding
46
New
10
Increased
16
Reduced
6
Closed
7
Top Buys
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$14M |
| 2 |
UnitedHealth
UNH
|
$6.5M |
| 3 |
Sanofi
SNY
|
$6.23M |
| 4 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$5.14M |
| 5 |
United Therapeutics
UTHR
|
$4.95M |
Top Sells
| 1 |
GSK
GSK
|
$10.6M |
| 2 |
Addus HomeCare
ADUS
|
$5.18M |
| 3 |
AET
Aetna Inc
AET
|
$5.1M |
| 4 |
Stryker
SYK
|
$3.18M |
| 5 |
Avanos Medical
AVNS
|
$2.43M |
Sector Composition
| 1 | Healthcare | 95.97% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $16.7M | 11.43% | 1,580,457 +487,466 | +45% | +$5.14M |
|
|
NEOS
2
DELISTED
Neos Therapeutics, Inc
NEOS
| $14M | 9.6% | +666,729 | New | +$14M |
|
3
Johnson & Johnson
JNJ
$427B
| $7.98M | 5.47% | 85,438 +21,261 | +33% | +$1.98M |
|
4
Medtronic
MDT
$119B
| $7.58M | 5.2% | 113,289 +57,889 | +104% | +$3.88M |
|
5
Cardinal Health
CAH
$35.5B
| $7.29M | 5% | 94,868 +31,590 | +50% | +$2.43M |
|
|
6
UnitedHealth
UNH
$281B
| $6.5M | 4.45% | +55,984 | New | +$6.5M |
|
|
7
Sanofi
SNY
$121B
| $6.23M | 4.27% | +131,271 | New | +$6.23M |
|
8
Cigna
CI
$80.3B
| $6.14M | 4.21% | 45,493 +27,853 | +158% | +$3.76M |
|
|
RXDX
9
DELISTED
Ignyta, Inc.
RXDX
| $5.99M | 4.11% | 682,306 +159,550 | +31% | +$1.4M |
|
10
Amgen
AMGN
$155B
| $5.23M | 3.59% | 37,832 +9,483 | +33% | +$1.31M |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.22M | 3.58% | 64,996 +37,996 | +141% | +$3.05M |
|
|
ANTH
12
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5.21M | 3.57% | 856,072 +617,914 | +259% | +$3.76M |
|
13
AbbVie
ABBV
$372B
| $5.13M | 3.52% | 94,316 +61,025 | +183% | +$3.32M |
|
|
DMK
14
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $5.06M | 3.47% | 1,306,860 +84,600 | +7% | +$327K |
|
|
15
United Therapeutics
UTHR
$13.8B
| $4.95M | 3.39% | +37,677 | New | +$4.95M |
|
16
Bristol-Myers Squibb
BMY
$96B
| $4.9M | 3.36% | +82,734 | New | +$4.9M |
|
17
Ascendis Pharma
ASND
$11.8B
| $4.78M | 3.27% | 269,785 +67,260 | +33% | +$1.19M |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $3.91M | 2.68% | 239,698 -80,302 | -25% | -$1.31M |
|
|
PFNX
19
DELISTED
Pfenex Inc.
PFNX
| $3.83M | 2.63% | 255,303 -90,825 | -26% | -$1.36M |
|
|
ACHN
20
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.52M | 1.73% | 364,368 +117,368 | +48% | +$811K |
|
|
FOMX
21
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.47M | 1.69% | 336,286 +175,000 | +109% | +$1.28M |
|
|
CYBX
22
DELISTED
CYBERONICS INC
CYBX
| $2.46M | 1.69% | +40,478 | New | +$2.46M |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.98M | 1.36% | 57,605 +49,597 | +619% | +$1.71M |
|
|
NTUS
24
DELISTED
Natus Medical Inc
NTUS
| $1.97M | 1.35% | +50,000 | New | +$1.97M |
|
|
ADMS
25
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.7M | 1.17% | +101,766 | New | +$1.7M |
|